Expanding the clinical tumor phenotype of the EPAS1 -asssociated tumor syndrome
The Journal of Clinical Endocrinology & Metabolism · 2026
DOI: 10.1210/clinem/dgag003 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Yasemin Cole und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genomic Medicine, University of Cambridge, Cambridge CB2 0QQ, UK. Hauptthemen laut MEDLINE: Basic Helix-Loop-Helix Proteins, Pancreatic Neoplasms, Pheochromocytoma, Neuroendocrine Tumors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NICHD, National Cancer Institute (NCI).
Abstract (Originalsprache)
Context
Since the original discovery of the Pacak-Zhuang syndrome (PZS) in 2012, defined by the clinical triad of pheochromocytoma/paraganglioma (PPGL) and/or duodenal ampullar somatostatinoma with erythrocytosis, multiple multisystemic phenotypes have been identified in patients with somatic mosaic pathogenic variants in EPAS1/HIF2A. Deep phenotyping of patients along with evaluation of a transgenic murine model has led to the understanding of the role of HIF-2α in developmental processes, including tumor development. Interestingly, pancreatic neuroendocrine tumors (NETs) occur in von Hippel-Lindau disease and the VHL gene product regulates HIF-2α expression.
Objective
Characterize pancreatic NETs in PZS.
Methods
We have reviewed the clinical records in the index patient at Addenbrooke’s Hospital (UK) and a cohort of patients with PZS from the NIH were assessed for pancreatic NETs.
Results
Herein, we describe a novel series from two institutions of patients with EPAS1-associated pancreatic neuroendocrine tumors including a case of a nonfunctioning pancreatic NET in association with an EPAS1 somatic mosaic variant.
Conclusion
This case study extends our current understanding of the phenotypic spectrum in PZS and links pancreatic NETs to an additional hypoxia-associated gene, namely EPAS1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genomic Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.
- Department of Endocrinology, Cambridge University Hospital, Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
- Molecular Genetic Laboratories, Cambridge University Hospital, Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
- Department of Radiology, Cambridge University Hospital, Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
- Aston Medical School, College of Health and Life Sciences, Birmingham B4 7ET, UK.
- Department of Haematology, Cambridge University Hospitals, NHS Foundation Trust, Cambridge CB2 0QQ, UK.
ORCID-Profile: Yasemin Cole, Zhengping Zhuang, Hussam Alkaissi, Ruth T Casey
Förderung
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- NICHD
- National Cancer Institute (NCI)
- National Institute of Neurological Disorders and Stroke (NINDS)
- National Heart, Lung, and Blood Institute (NHLBI)
- NIH
- US government
- US Department of Health and Human Services
Zitieren
APA
Cole, Y., Howarth, S., Javaid, A., Tarpey, P., Scoffings, D., Maher, E. R., Godfrey, A. L., Pacak, K., Zhuang, Z., Alkaissi, H., & Casey, R. T. (2026). Expanding the clinical tumor phenotype of the EPAS1 -asssociated tumor syndrome. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgag003
Vancouver
Cole Y, Howarth S, Javaid A, Tarpey P, Scoffings D, Maher ER, et al. Expanding the clinical tumor phenotype of the EPAS1 -asssociated tumor syndrome. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgag003
BibTeX
@article{Cole2026,
author = {Cole, Yasemin and Howarth, Sophie and Javaid, Asna and Tarpey, Patrick and Scoffings, Daniel and Maher, Eamonn R and Godfrey, Anna L and Pacak, Karel and Zhuang, Zhengping and Alkaissi, Hussam and Casey, Ruth T},
title = {Expanding the clinical tumor phenotype of the EPAS1 -asssociated tumor syndrome},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
doi = {10.1210/clinem/dgag003}
}
EUVIMED